Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Gujarat Themis Biosyn Ltd ( (IN:GUJTHEM) ).
Gujarat Themis Biosyn Ltd has announced the publication of its unaudited financial results for the quarter ending June 30, 2025, in the ‘Western Times’ newspaper. This disclosure is in compliance with SEBI’s Listing Obligations and Disclosure Requirements, indicating the company’s commitment to transparency and regulatory adherence. The publication of these financial results is a significant step for stakeholders, providing insights into the company’s financial health and operational performance for the specified quarter.
More about Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and other chemical products. The company is based in Gujarat, India, and has a market presence in both domestic and international markets.
Average Trading Volume: 27,716
Technical Sentiment Signal: Buy
Current Market Cap: 40.52B INR
Find detailed analytics on GUJTHEM stock on TipRanks’ Stock Analysis page.